New Nordic Healthbrands AB said its normalized net income for the third quarter came to 70 Swedish öre per share, an increase of 47.2% from 47 öre per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 4.3 million kronor, an increase of 47.2% from 2.9 million kronor in the year-earlier period.
The normalized profit margin climbed to 5.1% from 4.0% in the year-earlier period.
Total revenue grew 14.7% on an annual basis to 84.7 million kronor from 73.9 million kronor, and total operating expenses rose 12.4% from the prior-year period to 77.6 million kronor from 69.0 million kronor.
Reported net income rose 47.0% from the prior-year period to 5.5 million kronor, or 88 öre per share, from 3.7 million kronor, or 60 öre per share.
As of Oct. 31, US$1 was equivalent to 9.02 Swedish kronor.